Statins Cut Death Risk in Non-Obstructive CAD

Statin use is associated with a decreased risk of all-cause mortality among patients with non-obstructive coronary artery disease (CAD).
Statin use is associated with a decreased risk of all-cause mortality among patients with non-obstructive coronary artery disease (CAD).

Statin use is associated with a decreased risk of all-cause mortality among patients with non-obstructive coronary artery disease (CAD), according to a study published in Atherosclerosis (2015;239:335-342). 

The study included 8,372 patients with non-obstructive CAD documented by coronary computed tomography angiography (CCTA). Of these, 1,983 were prescribed statins (23.7%). Statin users had a 60% decreased risk of all-cause mortality and a 57% decreased risk of a composite endpoint of death or late coronary revascularization (more than 90 days after CCTA) compared with non-users, regardless of age, sex, presence of hypertension or diabetes, and other clinical factors.

Loading links....
You must be a registered member of Renal and Urology News to post a comment.

Newsletter Signup